These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 1794212

  • 1. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis.
    Yamakado M, Umezu M, Nagano M, Tagawa H.
    Clin Invest Med; 1991 Dec; 14(6):623-9. PubMed ID: 1794212
    [Abstract] [Full Text] [Related]

  • 2. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients.
    Hori K, Onoyama K, Iseki K, Fujimi S, Fujishima M.
    Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietin.
    Schwartz AB, Prior JE, Mintz GS, Kim KE, Kahn SB.
    Transplant Proc; 1991 Apr; 23(2):1827-30. PubMed ID: 2053168
    [Abstract] [Full Text] [Related]

  • 4. Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin (rHuEpo) therapy for renal anemia.
    Müller R, Steffen HM, Brunner R, Saric J, Pollok M, Baldamus CA, Kaufmann W.
    Clin Invest Med; 1991 Dec; 14(6):614-22. PubMed ID: 1665406
    [Abstract] [Full Text] [Related]

  • 5. Management of blood pressure changes during recombinant human erythropoietin therapy.
    Levin N.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):16-20. PubMed ID: 2669081
    [Abstract] [Full Text] [Related]

  • 6. Erythropoietin associated hypertension among pediatric dialysis patients.
    Komatsu Y, Ito K.
    Adv Perit Dial; 1992 Mar; 8():448-52. PubMed ID: 1361845
    [Abstract] [Full Text] [Related]

  • 7. Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO).
    Roger SD, Baker LR, Raine AE.
    Clin Nephrol; 1993 Feb; 39(2):103-10. PubMed ID: 8448912
    [Abstract] [Full Text] [Related]

  • 8. [Arterial hypertension in patients with chronic kidney insufficiency in hemodialysis with erythropoietin].
    Martins Prata M, Teixeira de Sousa F, Barbas J, Vinhaś J, Marques da Costa A.
    Rev Port Cardiol; 1990 Feb; 9(2):119-23. PubMed ID: 2346662
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H, Mimura T, Honda N.
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of recombinant human erythropoietin (rHuEpo) on the hemostatic system in chronic hemodialysis patients.
    Huraib S, al-Momen AK, Gader AM, Mitwalli A, Sulimani F, Abu-Aisha H.
    Clin Nephrol; 1991 Nov; 36(5):252-7. PubMed ID: 1752076
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
    de Sousa FT, Prata MM, Barbas JV, dos Santos JP.
    Acta Med Port; 1990 Nov; 3(6):347-52. PubMed ID: 2089856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.